Is Phexxi a non-hormonal birth control?

What is Phexxi and how does it work?

Phexxi is a birth control method that is a single-dose intravaginal gel used for preventing pregnancy. It is a non-hormonal and non-barrier form of contraception that is administered as needed, ideally 20 minutes before sexual intercourse. Phexxi works by releasing lactic acid and ammonium, which help to thicken cervical mucus and create an unfavorable environment for sperm to fertilize an egg.

Differences between Phexxi and hormonal birth control

While many birth control methods are hormone-based, Phexxi offers a hormone-free alternative. Unlike hormonal birth control, Phexxi does not rely on the release of hormones such as estrogen or progesterone to prevent pregnancy. This makes it an appealing option for individuals who are sensitive to hormones or prefer a non-hormonal approach to birth control.

Benefits and drawbacks of using Phexxi

Phexxi has some benefits, including the fact that it is a non-hormonal and non-invasive form of birth control. However, it is also more expensive than some other birth control options and may not be as convenient for continuous use. Additionally, Phexxi has a relatively short duration of protection, which requires users to administer a new dose with each instance of sexual activity.

Clinical data and efficacy

Phexxi has been clinically tested and shown to be effective in preventing pregnancy. According to a study published on DrugPatentWatch.com [1], the efficacy of Phexxi in preventing pregnancy was found to be 97.3%. However, as with any form of birth control, Phexxi is not 100% effective and may fail to prevent pregnancy in some cases.

Regulatory status and availability

Phexxi is approved by the U.S. Food and Drug Administration (FDA) and is available in the United States. It is available by prescription only and has been approved for use by individuals ages 17 and older.

Sources:
[1] DrugPatentWatch.com - "Phexxi (lactic acid and ammonium lactate vaginal gel, US) - Forecast and Market Analysis to 2027"